KeifeRx

Mclean, United States

KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.

$6.0M raised

Dec 2021

Series A

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about KeifeRx

How much funding has KeifeRx raised?

KeifeRx has raised $6.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.

Where is KeifeRx headquartered?

KeifeRx is headquartered in Mclean, United States.

What does KeifeRx do?

KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.

What stage is KeifeRx at?

KeifeRx is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 8, 2021.

MLA

"KeifeRx — Funding & Investors." VCBacked, December 8, 2021, https://www.vcbacked.co/company/keiferx. Accessed July 2, 2026.

APA

VCBacked. (2021). KeifeRx — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/keiferx

Wikipedia (cite web)

{{cite web |title=KeifeRx — Funding & Investors |url=https://www.vcbacked.co/company/keiferx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 8, 2021.